VYVANSE IN CANADA : A COMPREHENSIVE OVERVIEW

Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in Canada for managing Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals and grown-ups . The medication functions as a prodrug, meaning it’s dormant until metabolized by the body, releasing dextroamphetamine steadily